CytoDyn Inc. announced earnings results for the second quarter ended November 30, 2020. For the second quarter, the company announced operating loss was USD 24.503 million compared to USD 12.121 million a year ago. Net loss was USD 34.966 million compared to USD 14.860 million a year ago. Basic loss per share from continuing operations was USD 0.06 compared to USD 0.04 a year ago. For the half year, operating loss was USD 50.175 million compared to USD 24.753 million a year ago. Net loss was USD 65.798 million compared to USD 31.024 million a year ago. Basic loss per share from continuing operations was USD 0.12 compared to USD 0.08 a year ago.